Issue of Equity

RNS Number : 1887W
W.H. Ireland Group PLC
14 April 2023



WH Ireland Group Plc


(“WH Ireland” or the “Company”)


Issue of Equity

The Company announces that pursuant to the terms of the acquisition agreement for Harpsden Wealth Management Limited, announced on 30 November 2020, it has issued 2,841,538 ordinary shares of 5p each in the Company to certain of the sellers as part of the second deferred consideration.

Accordingly, the Company has today issued 2,841,538 Ordinary Shares (the “New Shares“). Application has been made to admit the New Shares to trading on AIM (“Admission“). Admission is expected to become effective on 19 April 2023 and the New Shares will rank pari passu in all respects with the Company’s existing ordinary shares in issues.

For the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (“DTRs“), the issued ordinary share capital of the Company following Admission will consist of 65,152,876 ordinary shares with voting rights attached (one vote per ordinary share). There are no ordinary shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company.

For further information please contact:

WH Ireland Group plc

Phillip Wale, Chief Executive Officer

+44(0) 20 7220 1666

Canaccord Genuity Limited

Emma Gabriel / Harry Rees               

+44(0) 20 7523 8000

MHP Communications

Reg Hoare            

+44 (0) 20 3128 8793




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.